From Investment to Deployment: Why Intellectual Property Matters in an Expanding Nuclear Energy Market
Key Takeaway: New federal initiatives are expanding access to private capital and deployment financing for nuclear energy technologies. Companies that fail to protect and clearly document their intellectual property may...
FDA Launches Expedited IND Pilot Program to Accelerate Human Trials, Raising IP Considerations for Sponsors
Key Takeaways: The Expedited Investigational New Drug (IND) Pilot Program is intended to evaluate whether leveraging qualified research institutions (QRIs) and a rolling review process can improve the efficiency of...
Patent, Protect, or Pause: Triaging AI-Drafted Invention Disclosures in Biopharma
Key Takeaway: As AI-drafted invention disclosures become more common, counsel are reading past the polished prose, and thinking harder about privilege, and confidentiality. If invention disclosures sound different lately, look...